| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.084 | 42.994 | 44.931 | 50.919 | 42.459 | 48.791 | 55.536 | 52.948 | 50.789 | 63.868 |
| Total Income - EUR | 34.436 | 47.738 | 45.635 | 52.819 | 42.827 | 52.128 | 58.570 | 54.326 | 51.399 | 64.715 |
| Total Expenses - EUR | 35.917 | 38.559 | 43.744 | 48.732 | 41.949 | 46.802 | 54.327 | 51.854 | 49.581 | 55.719 |
| Gross Profit/Loss - EUR | -1.481 | 9.179 | 1.891 | 4.087 | 877 | 5.326 | 4.243 | 2.472 | 1.818 | 8.996 |
| Net Profit/Loss - EUR | -2.516 | 8.221 | 1.435 | 3.561 | 450 | 5.009 | 3.757 | 1.941 | 1.314 | 8.057 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Flavoseb S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 693 | 389 | 990 | 323 | 0 | 0 | 0 | 0 | 940 |
| Current Assets | 10.925 | 14.910 | 14.928 | 10.852 | 11.824 | 15.564 | 18.951 | 24.207 | 43.752 | 72.752 |
| Inventories | 10.897 | 14.583 | 14.766 | 10.584 | 11.225 | 14.499 | 18.379 | 22.977 | 41.065 | 70.362 |
| Receivables | 18 | 18 | 18 | 0 | 164 | 953 | 208 | 220 | 220 | 1.570 |
| Cash | 9 | 308 | 144 | 268 | 435 | 112 | 364 | 1.010 | 2.467 | 820 |
| Shareholders Funds | -29.148 | -20.630 | -18.846 | -14.939 | -14.199 | -8.921 | -4.966 | -3.041 | -1.718 | 6.349 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.073 | 36.232 | 34.163 | 26.781 | 26.346 | 24.485 | 23.917 | 27.249 | 45.470 | 67.342 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Flavoseb S.r.l.